Roche confirms that its cobas MPXV test, as well as the LightMix® research use only kits, detect the latest mpox virus variants Basel, 20 August 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ...
Roche and its subsidiary TIB Molbiol have developed three different LightMix® Modular Virus kits for the detection of the monkeypox virus Multiple clusters of monkeypox virus have been reported in non ...
PLEASANTON, Calif., Dec. 29, 2014 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has provided an Emergency Use Authorization (EUA) ...
Roche announced that the Food and Drug Administration (FDA) has granted an Emergency Use Authorization (EUA) for the LightMix Ebola Zaire rRT-PCR Test for use in patients with signs and symptoms of ...
The Swiss pharmaceutical firm Roche has received an emergency authorization from the US Food and Drug Administration (US FDA) for LightMix Ebola Zaire test for emergency use on patients with signs and ...
Roche and its subsidiary TIB Molbiol have developed three unique LightMix Modular Virus kits in response to recent monkeypox virus concerns. Multiple clusters of the monkeypox virus have been reported ...
The U.S. Food and Drug Administration (FDA) has given Roche an Emergency Use Authorization (EUA) for the LightMix Zika rRT-PCR Test. According to an announcement made by Roche, the product is to be ...
PLEASANTON, California, June 20, 2016 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) and TIB MOLBIOL, GmbH, announced today the availability of the LightMix Modular Zika Virus Assay (CE) in ...
Roche is committed to supporting all those working to overcome the mpox outbreak by providing access to high-quality Polymerase Chain Reaction (PCR) testing Roche confirms that its cobas MPXV test, as ...
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has provided an Emergency Use Authorization (EUA) for the LightMix® Ebola Zaire rRT-PCR Test for use ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results